BlackDiamond Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
BlackDiamond Wealth Management's ABBV Position: Q3 2026 in Review
BlackDiamond Wealth Management increased its AbbVie (ABBV) stake by 15% in Q3 2026, buying an estimated $197K and bringing the position to 6,003 shares worth $1.76M. The position accounts for 0.68% of the portfolio, ranked #39.
BlackDiamond Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- BlackDiamond Wealth Management held 6,003 shares of AbbVie worth $1.76M as of Q3 2026.
- BlackDiamond Wealth Management bought 770 AbbVie shares in Q3 2026, an estimated $197K.
- AbbVie made up 0.68% of BlackDiamond Wealth Management's portfolio in Q3 2026, its #39 holding.
- BlackDiamond Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on BlackDiamond Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.